Bloch, Orin <br/><br/>
Disseminated progression of glioblastoma after treatment with bevacizumab.  [electronic resource] 

 -  Clinical neurology and neurosurgery  Sep 2013 
 - 1795-801 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-6968 
<br/><br/><label>Standard No.: </label>10.1016/j.clineuro.2013.04.017  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Angiogenesis Inhibitors--therapeutic use<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Bevacizumab<br/>Brain Neoplasms--drug therapy<br/>Disease Progression<br/>Disease-Free Survival<br/>Female<br/>Follow-Up Studies<br/>Glioblastoma--drug therapy<br/>Humans<br/>Karnofsky Performance Status<br/>Magnetic Resonance Imaging<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local<br/>Neoplasm, Residual<br/>Neurosurgical Procedures<br/>Retrospective Studies<br/>Survival Analysis<br/>Young Adult